CompoAtlas

Ultratransit

Food supplement declared in France, declaration No 2020-11-537

Ultratransit (Vitavea Santé) is a food supplement declared in France. Status: retiré du marché le 16 November 2025. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Vitavea Santé
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Retiré du marché le 16 November 2025
Form
Gélule
Daily dose
2
Directions for use
2 gélules avec un verre d'eau le soir au coucher
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Transit

Declaration 313636, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Tamarindus indica L.Fruit (pulpe)Extrait sec hydroalcoolique150 mg
Senna alexandrina Mill.FeuilleExtrait sec hydroalcoolique135 mg

Additives

E460, E470b

Other ingredients

Gélule végétale, maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas prolonger sans l'avis d'un spécialiste Ce complément alimentaire contient des plantes, il est recommandé de demander conseil à votre pharmacien

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Vitavea Santé

Enter to analyse, Shift+Enter for a new line